Illumina Acquires Edico Genome to Accelerate Genomic Data Analysis

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS). Edico Genome’s DRAGEN® Bio-IT Platform (DRAGEN) uses field programmable gate array (FPGA) technology in conjunction with proprietary software algorithms to reduce both data footprint and time to results. DRAGEN can be run on... Read more

Edico Genome Announces Flagship Global Distribution Partnership Program

SAN DIEGO — March 13, 2018 – Edico Genome, the leading secondary analysis solution provider for next-generation sequencing (NGS), today unveiled its DRAGENTM Global Distribution Partner Network, a new program broadening access to its DRAGEN Bio-IT Platform to markets around the world. The Global Distribution Partner Network will provide new and existing DRAGEN customers with regionally focused... Read more

Edico Genome Announces New Offering: Comprehensive Clinical Genomics Information System

SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology’s 2017 Annual Meeting (AMP), Edico Genome announced a new offering: the comprehensive DRAGEN Clinical Genomics Information System (CGIS). Designed to enable clinical laboratories of all sizes to quickly, simply and efficiently develop sequencing-based laboratory developed tests (LDTs), DRAGEN CGIS harnesses the power of... Read more

Edico Genome Partners with Children’s Hospital Los Angeles to Accelerate Diagnoses, Enhance Somatic and Germline Research Initiatives with DRAGEN Bio-IT Platform

SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles (CHLA). The hospital will utilize Edico Genome’s DRAGENTM Bio-IT platform to deliver enhanced patient care and accelerate research initiatives to expand test offerings for children with genetic disorders and cancer. CHLA... Read more

Edico Genome And Fabric Genomics Develop Integrated Solution For Genomic Analysis With The Goal Of Improving Clinical Care

Industry Leaders Partner to Provide Streamlined Variant Data Analysis Solution ORLANDO, Fla., Oct. 19, 2017 /PRNewswire/ — Today at the American Society for Human Genetics (ASHG) Annual Meeting, Edico Genome and Fabric Genomics announced their collaboration to provide an integrated solution for secondary and tertiary analysis of next-generation sequencing data. Through this partnership, users can seamlessly utilize Edico Genome’s DRAGENTM Bio-IT platform with Fabric... Read more

Edico Genome And South Africa’s Centre For Proteomic And Genomic Research Deploy First DRAGEN Bio-IT Platform In Africa

SAN DIEGO and CAPE TOWN, South Africa, Oct. 10, 2017 – Edico Genome and the Centre for Proteomic and Genomic Research (CPGR) today announced the deployment of the first DRAGENTM Bio-IT platform in Africa. Selected by CPGR to help drive adoption of precision medicine and genomics, DRAGEN will be made available to life science and biotech communities in South Africa. The DRAGEN card is... Read more

Edico Genome’s DRAGEN Now Available on Illumina’s BaseSpace Sequence Hub

September 19, 2017—SAN DIEGO – Edico Genome today announced the availability of its DRAGENTM Bio-IT Platform on Illumina’s BaseSpace® Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data. Powered by Amazon Web Services’ (AWS) new reconfigurable Field Programmable Gate Array (FPGA) enabled F1 instances, Edico Genome’s ultra-rapid DRAGEN Genome... Read more

Edico Genome Launches DRAGEN On DNAnexus’ Platform

SAN DIEGO, Aug. 30, 2017 /PRNewswire/ — Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome’s DRAGEN™ on DNAnexus’ genome informatics and data management platform. Through this integration, new and existing DNAnexus customers will be able to utilize DRAGEN’s ultra-rapid Genome Pipeline, significantly reducing costs and turnaround time while enhancing accuracy. DNAnexus provides a global network for sharing... Read more

Edico Genome Signs Contracts With NHGRI And NCI For Use Of DRAGEN For Cancer Research

SAN DIEGO, Aug. 2, 2017 — Edico Genome today announced it has signed contracts with the National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI) for the use of its DRAGENTM(Dynamic Read Analysis for Genomics) Bio-IT platform. Continuing their initiatives to advance cancer research, NHGRI and NCI purchased Edico Genome’s DRAGEN Somatic pipeline and DRAGEN Genome pipeline, ensuring accuracy, reducing costs... Read more